Your browser doesn't support javascript.
loading
Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
Morales-Santana, Sonia; Díez-Pérez, Adolfo; Olmos, José M; Nogués, Xavier; Sosa, Manuel; Díaz-Curiel, Manuel; Pérez-Castrillón, José L; Pérez-Cano, Ramón; Torrijos, Antonio; Jodar, Esteban; Rio, Luis Del; Caeiro-Rey, José R; Reyes-García, Rebeca; García-Fontana, Beatriz; González-Macías, Jesús; Muñoz-Torres, Manuel.
Afiliação
  • Morales-Santana S; Metabolic Bone Unit, Endocrinology Division (RETICEF), Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; RETICEF, Instituto de Salud Carlos III, Spain; Proteomic Research Service, Hospital Universitario San Cecilio, Instituto de Investigación
  • Díez-Pérez A; RETICEF, Instituto de Salud Carlos III, Spain; Hospital del Mar-IMIM-UAB, Department of Internal Medicine, Barcelona, Spain.
  • Olmos JM; RETICEF, Instituto de Salud Carlos III, Spain; Hospital Universitario Marqués Valdecilla, Department of Internal Medicine, Santander, Spain.
  • Nogués X; RETICEF, Instituto de Salud Carlos III, Spain; Hospital del Mar-IMIM-UAB, Department of Internal Medicine, Barcelona, Spain.
  • Sosa M; Osteoporosis Research Group. Universidad de Las Palmas de Gran Canaria. Las Palmas de Gran Canaria, Spain.
  • Díaz-Curiel M; RETICEF, Instituto de Salud Carlos III, Spain; Fundación Jiménez Díaz, Department of Internal Medicine, Madrid, Spain.
  • Pérez-Castrillón JL; RETICEF, Instituto de Salud Carlos III, Spain; Hospital Universitario Río Ortega, Department of Internal Medicine, Valladolid, Spain.
  • Pérez-Cano R; RETICEF, Instituto de Salud Carlos III, Spain; Hospital Virgen Macarena. Department of Internal Medicine, Sevilla, Spain.
  • Torrijos A; RETICEF, Instituto de Salud Carlos III, Spain; Hospital La Paz, Department of Rheumatology, Madrid, Spain.
  • Jodar E; RETICEF, Instituto de Salud Carlos III, Spain; Hospital Universitario Quirón, Department of Endocrinology, Madrid, Spain.
  • Rio LD; RETICEF, Instituto de Salud Carlos III, Spain; CETIR Medical Centre, Barcelona, Spain.
  • Caeiro-Rey JR; RETICEF, Instituto de Salud Carlos III, Spain; Trabeculae, Ourense, Spain.
  • Reyes-García R; Metabolic Bone Unit, Endocrinology Division (RETICEF), Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; RETICEF, Instituto de Salud Carlos III, Spain.
  • García-Fontana B; Metabolic Bone Unit, Endocrinology Division (RETICEF), Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; RETICEF, Instituto de Salud Carlos III, Spain.
  • González-Macías J; RETICEF, Instituto de Salud Carlos III, Spain; Hospital Universitario Marqués Valdecilla, Department of Internal Medicine, Santander, Spain.
  • Muñoz-Torres M; Metabolic Bone Unit, Endocrinology Division (RETICEF), Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria (ibs.GRANADA), Granada, Spain; RETICEF, Instituto de Salud Carlos III, Spain. Electronic address: mmt@mamuto.es.
Maturitas ; 82(4): 402-10, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26358930

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose Pós-Menopausa / Proteínas Morfogenéticas Ósseas / Difosfonatos / Estradiol / Conservadores da Densidade Óssea / Fraturas por Osteoporose Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose Pós-Menopausa / Proteínas Morfogenéticas Ósseas / Difosfonatos / Estradiol / Conservadores da Densidade Óssea / Fraturas por Osteoporose Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article